Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal function during ticrynafen therapy.

M A Beg, W Zuccarello, M A Donikian

    Nephron
    |January 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neurological complications in patients with Plasmodium vivax malaria from Karachi, Pakistan.

    The journal of the Royal College of Physicians of Edinburgh·2018
    Same author

    Association of Helicobacter pylori and protozoal parasites in patients with chronic diarrhoea.

    British journal of biomedical science·2018
    Same author

    Current situation and challenges in implementing Malaria control strategies in Pakistan.

    Critical reviews in microbiology·2014
    Same author

    The emerging threat of schistosomiasis spread in Pakistan.

    Tropical biomedicine·2014
    Same author

    Role of PGF2α in luteolysis based on inhibition of PGF2α synthesis in the mare.

    Theriogenology·2013
    Same author

    Endocrinology of number of follicular waves per estrous cycle and contralateral or ipsilateral relationship between corpus luteum and preovulatory follicle in heifers.

    Domestic animal endocrinology·2013
    Same journal

    Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

    Nephron·2026
    Same journal

    Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

    Nephron·2026
    Same journal

    Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

    Nephron·2026
    Same journal

    Prevalence of COVID-19 Pneumonia and Clinical Characteristics in Hemodialysis Patients During the SARS-CoV-2 Omicron Pandemic.

    Nephron·2026
    Same journal

    Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

    Nephron·2026
    Same journal

    Long-Term Therapy with Eculizumab Biosimilar in Patients with Atypical Haemolytic Uraemic Syndrome: Outcomes of a Prospective Observational Study.

    Nephron·2026
    See all related articles

    Ticrynafen and hydrochlorothiazide effectively treated hypertension and heart failure with similar efficacy. Ticrynafen uniquely reduced serum uric acid levels, unlike hydrochlorothiazide.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Nephrology

    Background:

    • Essential hypertension and congestive cardiac failure are significant cardiovascular conditions.
    • Diuretics are commonly used for managing these conditions.
    • Hydrochlorothiazide is a widely prescribed diuretic, but its effect on uric acid levels is known.

    Purpose of the Study:

    • To compare the efficacy and safety of ticrynafen and hydrochlorothiazide in patients with essential hypertension or congestive cardiac failure.
    • To evaluate the impact of both drugs on renal function.
    • To assess the differential effects on serum uric acid levels.

    Main Methods:

    • A comparative study involving 526 patients.
    • Treatment with ticrynafen (250--500 mg/day) or hydrochlorothiazide (50--100 mg/day).

    Related Experiment Videos

  • Duration of treatment ranged from 6 weeks to 6 months, with monitoring of renal function and serum uric acid.

    • Main Results:

    • Both ticrynafen and hydrochlorothiazide demonstrated similar antihypertensive activity and effectiveness in managing congestive cardiac failure symptoms.
    • No significant adverse effects on renal function (blood urea nitrogen, serum creatinine) were observed with either drug.
    • Ticrynafen significantly reduced serum uric acid levels, whereas hydrochlorothiazide led to elevated levels.

    Conclusions:

    • Ticrynafen and hydrochlorothiazide are effective treatments for hypertension and congestive cardiac failure with comparable safety profiles regarding renal function.
    • Ticrynafen offers a distinct advantage by lowering serum uric acid, potentially benefiting patients with hyperuricemia.
    • The choice between ticrynafen and hydrochlorothiazide may depend on the patient's uric acid status.